FABP5

Across TCGA pan-cancer cohorts, FABP5 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated FABP5 data layer compared with 24 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher FABP5 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated FABP5 expression acts as an unfavorable survival marker, although some lineages such as LSCC and HNSC show a favorable association.

CCRCC, LUAD, and GBM are the cancer types where FABP5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.597	0.875	<.001	63	view →
LUAD	OS	Median	All	0.609	0.955	.001	27	view →
GBM	OS	Quartile	All	0.728	0.868	.014	15	view →
LSCC	OS	Median	All	1.000	0.936	.009	12	view →
HNSC	OS	Tertile	All	0.763	0.546	.020	3	view →
PDAC	OS	Tertile	IV	0.934	0.425	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FABP5–CCRCC (DFS)

Open the CCRCC breakdown →